Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder

Oral Supplementation of Gangliosides - A Potential Treatment for GM3 Synthase Deficiency

The purpose of this pilot project is to see if a supplemental form of dietary gangliosides can serve as a potential treatment for the rare metabolic condition called ganglioside GM3 synthase deficiency.

Inclusion Criteria:

• Clinical diagnosis of GM3 synthase deficiency

Exclusion Criteria:

-